FDA Grants Approval for Gadobutrol ANDA219287 by Viwit Pharm
The FDA has granted approval for the ANDA219287 application for Gadobutrol submitted by Viwit Pharm.
Therapeutic Area
Therapeutic area intelligence for Contrast Agent with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.